TransMedics, Inc.
Edit

TransMedics, Inc.

http://www.transmedics.com/
Last activity: 31.07.2024
Active
Categories: CareHardwareHumanLifeMedTechTechnology
The TransMedics Organ Care System (OCS™) is a revolutionary organ transplant therapy which has the potential to save more patients’ lives
Website visits
8K /mo.
Mentions
36
Employees: 51-200
Total raised: $107.35M
Founded date: 1998

Investors 3

Funding Rounds 3

DateSeriesAmountInvestors
26.05.2016-$51.2M-
04.06.2015-$20M-
27.11.2012-$36.15M-

Mentions in press and media 36

DateTitleDescription
31.07.2024TransMedics Reports Second Quarter 2024 Financial ResultsANDOVER, Mass., July 31, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa...
18.07.2024TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)ANDOVER, Mass., July 18, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa...
17.07.2024TransMedics to Report Second Quarter 2024 Financial Results on July 31, 2024ANDOVER, Mass., July 17, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver fai...
21.06.2024TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)ANDOVER, Mass., June 21, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver fa...
30.04.2024TransMedics Reports First Quarter 2024 Financial ResultsANDOVER, Mass., April 30, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver f...
04.04.2024Технология, позволяющая органам работать вне телаПерфузия позволяет сохранить жизнь донорского органа вне тела, что даёт хирургам дополнительное время и увеличивает количество возможных трансплантаций. Перфузионный аппарат, в котором находится печень умершего донора. Аппарат перекачивает ...
18.08.2023TransMedics Completes Acquisition of Summit AviationTransMedics (Nasdaq: TMDX), an Andover, MA-based medical technology company, acquired Summit Aviation, a charter flight operator. The amount of the deal was not disclosed. The acquisition enables the establishment of TransMedics Aviation as...
17.04.2023TransMedics to Report First Quarter 2023 Financial Results on May 1, 2023ANDOVER, Mass., April 17, 2023 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") TMDX, a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, tod...
15.09.2022CIBC Innovation Banking Provides $60 Million Debt Financing to TransMedics Group Inc.BOSTON–(BUSINESS WIRE)–September 15, 2022– CIBC Innovation Banking is pleased to announce a new debt financing for Massachusetts-based TransMedics Group, Inc. (“TransMedics”), a market leading medical technology company that focuses on orga...
24.06.2022Organ Preservation Market is anticipated to reach a market value of USD 377.97 million by 2030, with a CAGR of 6.93%The value of the organ preservation market in 2020 was worth USD 193.49 million and is expected to grow at a CAGR of 6.93%, and it is expected to reach a market value of USD 377.97 million by 2030. /EIN News/ -- New York, United States, Jun...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In